305 related articles for article (PubMed ID: 10897122)
1. Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia.
Muñoz L; López O; Martino R; Brunet S; Bellido M; Rubiol E; Sierra J; Nomdedéu JF
Haematologica; 2000 Jul; 85(7):704-10. PubMed ID: 10897122
[TBL] [Abstract][Full Text] [Related]
2. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation for Philadelphia-chromosome-positive acute lymphoblastic leukemia.
Stockschläder M; Hegewisch-Becker S; Krüger W; tom Dieck A; Mross K; Hoffknecht M; Berger C; Kohlschütter B; Martin H; Peters S
Bone Marrow Transplant; 1995 Nov; 16(5):663-7. PubMed ID: 8547863
[TBL] [Abstract][Full Text] [Related]
4. Purging of peripheral blood stem cells yields BCR-ABL-negative autografts in patients with BCR-ABL-positive acute lymphoblastic leukemia.
Martin H; Atta J; Zumpe P; Eder M; Elsner S; Rode C; Wassmann B; Bruecher J; Hoelzer D
Exp Hematol; 1995 Dec; 23(14):1612-8. PubMed ID: 8542955
[TBL] [Abstract][Full Text] [Related]
5. [Detection of minimal residual disease in acute leukemias by immunophenotyping of bone marrow cells].
Deptała A; Widzyńska I; Kuratowska Z
Acta Haematol Pol; 1995; 26(4):403-11. PubMed ID: 8571742
[TBL] [Abstract][Full Text] [Related]
6. Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation.
Seriu T; Yokota S; Nakao M; Misawa S; Takaue Y; Koizumi S; Kawai S; Fujimoto T
Leukemia; 1995 Apr; 9(4):615-23. PubMed ID: 7723394
[TBL] [Abstract][Full Text] [Related]
7. [Children with acute lymphoblastic leukemia: prognostic significance of polymerase-chain-reaction analysis of minimal residual disease].
Steenbergen EJ; Verhagen OJ; van den Berg H; van Leeuwen EF; von dem Borne AE; van der Schoot CE
Ned Tijdschr Geneeskd; 1996 Jan; 140(1):22-8. PubMed ID: 8569906
[TBL] [Abstract][Full Text] [Related]
8. Detection of minimal residual disease in patients with childhood common acute lymphoblastic leukemia after autologous bone marrow transplantation with ex vivo purging and systemic IL-2 infusion: unsuccessful prediction of subsequent relapse.
Kiyoi H; Kojima S; Kato K; Matsuyama T; Kodera Y; Ohno R; Naoe T
Bone Marrow Transplant; 1995 Sep; 16(3):437-42. PubMed ID: 8535317
[TBL] [Abstract][Full Text] [Related]
9. Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia.
Steenbergen EJ; Verhagen OJ; van Leeuwen EF; van den Berg H; Behrendt H; Slater RM; von dem Borne AE; van der Schoot CE
Leukemia; 1995 Oct; 9(10):1726-34. PubMed ID: 7564517
[TBL] [Abstract][Full Text] [Related]
10. Residual leukemia and immunomagnetic bead purging in patients with BCR-ABL-positive acute lymphoblastic leukemia.
Atta J; Martin H; Bruecher J; Elsner S; Wassmann B; Rode C; Russ A; Kvalheim G; Hoelzer D
Bone Marrow Transplant; 1996 Sep; 18(3):541-8. PubMed ID: 8879615
[TBL] [Abstract][Full Text] [Related]
11. Detection of minimal residual disease using clonospecific primers for CDRIII in patients with acute B lymphocytic leukemia with or without Philadelphia chromosome: possibility of clinical application as a tool for improving prognosis.
Maeda Y; Horiuchi F; Morita S; Matsuda M; Shirakawa C; Masaki H; Koyama A; Hamazaki H; Fujimoto T; Irimajiri K
Exp Hematol; 1994 Aug; 22(9):881-7. PubMed ID: 8062887
[TBL] [Abstract][Full Text] [Related]
12. Detection of minimal residual disease in acute leukemia patients.
van Dongen JJ; Szczepański T; de Bruijn MA; van den Beemd MW; de Bruin-Versteeg S; Wijkhuijs JM; Tibbe GJ; van Gastel-Mol EJ; Groeneveld K; Hooijkaas H
Cytokines Mol Ther; 1996 Jun; 2(2):121-33. PubMed ID: 9384697
[TBL] [Abstract][Full Text] [Related]
13. Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrow.
van Rhee F; Marks DI; Lin F; Szydlo RM; Hochhaus A; Treleaven J; Delord C; Cross NC; Goldman JM
Leukemia; 1995 Feb; 9(2):329-35. PubMed ID: 7869772
[TBL] [Abstract][Full Text] [Related]
14. Application of the polymerase chain reaction for detection of minimal residual disease of hematologic malignancies.
Roth MS; Terry VH
Henry Ford Hosp Med J; 1991; 39(2):112-6. PubMed ID: 1890004
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease.
Drach J; Drach D; Glassl H; Gattringer C; Huber H
Cytometry; 1992; 13(8):893-901. PubMed ID: 1459006
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance and prognostic detection of minimal residual disease in acute leukemias].
Deptała A; Widzyńska I; Kuratowska Z
Acta Haematol Pol; 1995; 26(4):413-20. PubMed ID: 8571743
[TBL] [Abstract][Full Text] [Related]
17. Detection of minimal residual disease in leukemia using polymerase chain reaction and restriction analysis.
Wu N; Lu S; Zhu P; Liu L; Peng Y
Chin Med J (Engl); 1997 Jan; 110(1):73-7. PubMed ID: 9594329
[TBL] [Abstract][Full Text] [Related]
18. [The clinical significance of minimal residual disease of acute leukemia with t(4;11) (q21;q23)].
Okamura T; Park YD; Inoue M; Yasui M; Ueno M; Endo C; Yagi K; Kawa K
Rinsho Ketsueki; 1996 Nov; 37(11):1318-21. PubMed ID: 8960669
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric determination of leukemia-associated marker combinations for the study of minimal residual disease.
Babusíková O; Glasová M; Kusenda J; Koníková E; Mésárosová A
Neoplasma; 1994; 41(6):305-13. PubMed ID: 7870213
[TBL] [Abstract][Full Text] [Related]
20. [Detection of minimal residual disease using reverse transcriptase polymerase chain reaction technique].
Numata S; Kato K; Horibe K
Nihon Rinsho; 1992 Jun; 50(6):1380-5. PubMed ID: 1381448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
